$OPENAI - AI models will continuously improve, with current models being the worst we'll ever use, suggesting significant upside potential for AI companies
$PHARMA - AI can significantly accelerate drug discovery by intelligently pruning search spaces and speeding up regulatory processes, with active commercial pilots already underway
$FUSION - Fusion energy has shown small-scale proof of concept and AI could potentially accelerate its development, though scaling challenges remain
$ENERGY - Energy infrastructure will see significant investment as a spillover effect from AI compute demands, similar to how mobile technology drove battery improvements
Bearish:
$RESEARCH - Traditional research methods face disruption as there's a significant gap between AI capabilities and actual adoption in the scientific community